Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kavi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|January 14, 1989
Causes of the haemolytic uraemic syndromeJ Kavi, R Wise
Lancet (London, England)|April 30, 1988
Group A beta-haemolytic Streptococcus causing disseminated intravascular coagulation and maternal deathJ Kavi, R Wise
British Medical Journal (Clinical Research Ed.)|October 19, 1985
Polymicrobial infection in enteritisJ Kavi, R H George
Lancet (London, England)|May 28, 1988
Yersinia and haemolytic uraemic syndromeJ Kavi, P E Rose
Lancet (London, England)|September 3, 1988
Pathogenesis of haemolytic uraemic syndromeP E Rose, C M Taylor, J Kavi
Lancet (London, England)|October 31, 1987
Cytopathic effect of verotoxin on endothelial cellsJ Kavi, I Chant, M Maris, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1989
Intraperitoneal penetration of cefpiromeJ Kavi, J P Ashby, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1988
A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycinJ Kavi, J M Webberley, J M Andrews, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1989
Tissue penetration and pharmacokinetics of lomefloxacin following multiple dosesJ Kavi, J Stone, J M Andrews, et al.
Acute Medicine|May 17, 2011
Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical UnitYin May Yan, Manjit Singh, Karl Tonks, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|January 14, 1989
Causes of the haemolytic uraemic syndromeJ Kavi, R Wise
Lancet (London, England)|April 30, 1988
Group A beta-haemolytic Streptococcus causing disseminated intravascular coagulation and maternal deathJ Kavi, R Wise
British Medical Journal (Clinical Research Ed.)|October 19, 1985
Polymicrobial infection in enteritisJ Kavi, R H George
Lancet (London, England)|May 28, 1988
Yersinia and haemolytic uraemic syndromeJ Kavi, P E Rose
Lancet (London, England)|September 3, 1988
Pathogenesis of haemolytic uraemic syndromeP E Rose, C M Taylor, J Kavi
Lancet (London, England)|October 31, 1987
Cytopathic effect of verotoxin on endothelial cellsJ Kavi, I Chant, M Maris, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1989
Intraperitoneal penetration of cefpiromeJ Kavi, J P Ashby, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1988
A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycinJ Kavi, J M Webberley, J M Andrews, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1989
Tissue penetration and pharmacokinetics of lomefloxacin following multiple dosesJ Kavi, J Stone, J M Andrews, et al.
Acute Medicine|May 17, 2011
Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical UnitYin May Yan, Manjit Singh, Karl Tonks, et al.
Pageof 2